Glow Lifetech Corp. (GLWLF)
USD 0.04
(-10.06%)
USD 0.04
(-10.06%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.26 Million CAD | 25.44% |
| 2022 | -1.25 Million USD | 69.57% |
| 2021 | -4.13 Million USD | -3335.02% |
| 2020 | - USD | 14.53% |
| 2019 | - USD | -0.44% |
| 2018 | -140.32 Thousand USD | 61.62% |
| 2017 | -365.63 Thousand USD | -224.77% |
| 2016 | -112.58 Thousand USD | 11.2% |
| 2015 | -126.78 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -133.23 Thousand USD | 40.77% |
| 2024 Q2 | -122.28 Thousand USD | 12.66% |
| 2023 FY | - USD | 25.44% |
| 2023 Q4 | -242.82 Thousand USD | -9.21% |
| 2023 Q3 | -222.35 Thousand USD | 10.83% |
| 2023 Q2 | -249.35 Thousand USD | -33.55% |
| 2023 Q1 | -186.71 Thousand USD | 29.34% |
| 2022 Q4 | -264.23 Thousand USD | -38.8% |
| 2022 FY | - USD | 69.57% |
| 2022 Q3 | -190.37 Thousand USD | 49.07% |
| 2022 Q2 | -373.81 Thousand CAD | 22.57% |
| 2022 Q1 | -482.8 Thousand CAD | 19.1% |
| 2021 Q1 | -2.49 Million CAD | -25150.43% |
| 2021 Q4 | -596.81 Thousand CAD | -65.35% |
| 2021 FY | - USD | -3335.02% |
| 2021 Q3 | -360.94 Thousand CAD | 61.74% |
| 2021 Q2 | -943.47 Thousand CAD | 62.18% |
| 2020 Q4 | 9958.00 CAD | 101.44% |
| 2020 FY | - USD | 14.53% |
| 2020 Q3 | -691.52 Thousand CAD | -1679.42% |
| 2020 Q2 | -38.86 Thousand CAD | 1.13% |
| 2020 Q1 | -39.3 Thousand CAD | 20.82% |
| 2019 Q1 | -21.58 Thousand CAD | 0.0% |
| 2019 FY | - USD | -0.44% |
| 2019 Q4 | -49.63 Thousand CAD | -40.29% |
| 2019 Q3 | -35.38 Thousand CAD | 53.55% |
| 2019 Q2 | -76.16 Thousand CAD | -252.87% |
| 2018 FY | - USD | 61.62% |
| 2017 FY | - USD | -224.77% |
| 2016 FY | - USD | 11.2% |
| 2015 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 98.222% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 78.697% |
| SQZ Biotechnologies Company | -64.14 Million USD | 98.031% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 92.729% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 101.343% |
| Mesoblast Limited | -62.38 Million USD | 97.976% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 17.773% |
| Genus plc | 73.7 Million USD | 101.714% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 80.896% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 64.391% |
| Marizyme, Inc. | -34.28 Million USD | 96.316% |
| ContraFect Corporation | -64.99 Million USD | 98.057% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 85.601% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 72.095% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 9.899% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 52.238% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 45.648% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -143.809% |
| Accustem Sciences Inc. | -3.74 Million USD | 66.287% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 97.381% |
| EV Biologics, Inc. | -1.26 Million USD | 0.323% |
| Q BioMed Inc. | -617.62 Thousand USD | -104.499% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 135.36% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -99.72% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 44.712% |
| Biomind Labs Inc. | -1.03 Million USD | -22.086% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 112.788% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 82.363% |
| Skye Bioscience, Inc. | -13.54 Million USD | 90.677% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 15.085% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -4952.172% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 67.484% |
| IMV Inc. | -35.52 Million USD | 96.444% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 92.041% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 49.518% |
| GB Sciences, Inc. | -1.41 Million USD | 11.046% |
| Alpha Cognition Inc. | -9.7 Million USD | 86.986% |
| HST Global, Inc. | -5303.00 USD | -23717.518% |
| CSL Limited | 4.78 Billion USD | 100.026% |
| Halberd Corporation | -74.27 Thousand USD | -1600.404% |
| Enzolytics Inc. | -2.12 Million USD | 40.479% |
| Resverlogix Corp. | -11.74 Million USD | 89.243% |
| Affymax, Inc. | -14.29 Million USD | 91.164% |
| SYBLEU INC | -141.57 Thousand USD | -792.162% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 58.765% |
| argenx SE | -216.02 Million USD | 99.415% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 97.718% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 203.783% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 15.736% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 433.394% |
| AVAX Technologies, Inc. | -6.11 Million USD | 79.337% |
| Zenith Capital Corp. | -8.6 Million USD | 85.324% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.492% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -7150.118% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 48.373% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -617.539% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 96.813% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 56.331% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -20.714% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 18884.102% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 27.826% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 34.248% |
| BioStem Technologies, Inc. | -7.55 Million USD | 83.279% |
| ONE Bio Corp. | 13.61 Million USD | 109.278% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -597.475% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 38.598% |
| Agentix Corp. | -1.37 Million USD | 7.925% |
| LadRx Corporation | 412.28 Thousand USD | 406.353% |
| Cell Source, Inc. | -4.27 Million USD | 70.438% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -243.946% |
| Regen BioPharma, Inc. | 1.46 Million USD | 186.158% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -34.804% |
| NovAccess Global Inc. | -1.03 Million USD | -22.057% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 114.266% |
| Itoco Inc. | -1.86 Million USD | 32.421% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -232.712% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -13.176% |
| Kadimastem Ltd | -2.62 Million USD | 51.873% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -428.138% |
| CytoDyn Inc. | -18.02 Million USD | 92.994% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -1498.202% |
| Mobile Lads Corp. | -2.24 Million USD | 43.643% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -10228.261% |
| Qrons Inc. | -40.08 Thousand USD | -3051.226% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -160.058% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 339.47% |
| Rebus Holdings, Inc. | -951 Thousand USD | -32.812% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -18.929% |
| International Stem Cell Corporation | 202 Thousand USD | 725.269% |
| Bioxytran, Inc. | -3.82 Million USD | 66.937% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -2299.398% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 48.697% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 96.479% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -2706.762% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 53.87% |
| Neutra Corp. | -181.24 Thousand USD | -596.863% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 93.735% |
| PureTech Health plc | -11.62 Million USD | 89.137% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 93.734% |
| IXICO plc | -707 Thousand USD | -78.648% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 83.565% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 97.387% |
| CSL Limited | 4.73 Billion USD | 100.027% |
| Cellectis S.A. | -92.63 Million USD | 98.637% |